GWave is a non-invasive continuous glucose monitoring technology solution.
GWave has raised $5.0M in total funding. The most recent round was Series C. The last funding was announced in August 2023.
GWave's investors include Columbia Pacific Advisors.
GWave is headquartered in Tel Aviv, Israel.
GWave is a non-invasive continuous glucose monitoring technology solution.
GWave is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GWave — Funding & Investors." VCBacked, August 10, 2023, https://www.vcbacked.co/company/gwave. Accessed July 20, 2026.
VCBacked. (2023). GWave — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/gwave
{{cite web |title=GWave — Funding & Investors |url=https://www.vcbacked.co/company/gwave |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated